The Latest Breaking News from NYSE

Nike Beats on Earnings But Struggles in China and Faces Tariffs

Apparel behemoth Nike just released its latest earnings as the firm works to revamp its business. Should investors buy in or look elsewhere for opportunities?

MarketBeat · Dec 19, 2025

Is the AI Boom a Bubble? These 2 Dividend Stocks Say No

Looking for AI stocks with staying power—or a hedge if the bubble bursts? Discover two dividend-paying companies built for both 2026 outcomes.

MarketBeat · Dec 19, 2025

Forget the Chips: 4 Industrial Plays for the AI Rebound

Investors can capture the next phase of the artificial intelligence boom by focusing on the industrial companies building the physical data center backbone.

MarketBeat · Dec 18, 2025

Massive Breakout in Industrials: 3 Must-Watch Stocks Now

The industrials sector is showing signs of leadership, with XLI breaking out of a lengthy consolidation and outperforming the broader market in the short term.

MarketBeat · Dec 17, 2025

David Tepper Offloads Intel, Slashes UnitedHealth Stake in Q3 to Buy This Lesser-Known Stock

In Q3, Appaloosa's David Tepper sold his entire stake in Intel and reduced his UnitedHealth Group holdings by over 90% to invest $400 million in Whirlpool shares.

International Business Times UK · Dec 17, 2025

Smart Money Is Buying Auto Suppliers, Not Car Brands

Suppliers Magna and Autoliv offer deep value and steady income by building the essential infrastructure for every major car brand in the global market.

MarketBeat · Dec 16, 2025

3 AI Names With Big Buybacks: GEV, PSTG, and LSCC Signal Confidence

GEV, PSTG, and LSCC are three AI stocks lifting their buyback authorizations. After a massive 27% drop, PSTG's announcement is a clear signal of confidence.

MarketBeat · Dec 16, 2025

3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most

Healthcare behemoths, including the biggest name of them all, are increasing their dividends. Additionally, AMGN's dividend yield now sits solidly above 3%.

MarketBeat · Dec 16, 2025

Pfizer Adds to Its Big Bet on Weight Loss Drugs

A month after acquiring obesity biotech Metsera, Pfizer's expanding in the weight loss drug market after signing a licensing agreement for a weight loss pill.

MarketBeat · Dec 16, 2025

Financial Sector Breaks Out as Capital Rotates and Leadership Shifts

The financial sector has broken out of a multi-month consolidation, with XLF clearing $54 resistance, signaling renewed momentum and signs of sector leadership.

MarketBeat · Dec 15, 2025